CVE-2026-54143tinyhumansai openhuman OS command injection
CVE-2026-54143 is a OS command injection in tinyhumansai openhuman, rated critical (9.8 on CVSS 3.1).
Why this priority: Critical, and reachable over the network without an account.
Published · Updated · NVD status: Deferred
What it is
Input reaches an operating-system command line, letting an attacker run their own commands on the host. The software does not check, or checks wrongly, whether a caller may do something.
How it is reached
An attacker can exploit it over the network, without an account, and nobody has to click anything.
What an attacker gains
A successful attack can read the data it protects, change data or behaviour and take it offline. In practice, this kind of flaw lets an attacker run commands or code with the privileges of the affected service.
Is it being exploited?
CISA's SSVC assessment notes a public proof of concept. It can be exploited automatically, at scale. EPSS estimates a 1.2% chance of exploitation activity in the next 30 days, higher than 68% of scored CVEs.
What to do
- Upgrade tinyhumansai openhuman to 0.57.13 or later.
- Until it is patched, keep it off the internet or behind a VPN, allowlist or authenticating proxy.
Description from NVD
OpenHuman is an open-source agent harness available as a desktop application and Rust library. Before version 0.57.13, an attacker who can send messages to a configured external channel can cause the agent to create persistent shell cron jobs without human approval. The scheduler later executes these jobs with the privileges of the OpenHuman runtime user. Command validation also permits leading environment assignments that can redirect allowed commands to executable helpers. The demonstrated exploit requires a suitable helper executable already present on the host. This can lead to unauthorized persistent command execution and compromise data and resources accessible to OpenHuman. This issue is fixed in version 0.57.13.
What this means for your architecture.
A CVE names a product. Whether it matters depends on where that product sits in your systems: what reaches it, which trust boundary it guards and what it can reach once compromised. Veriom maps your components, their relationships and your trust boundaries from your code, cloud and delivery evidence, so you can see where a component like this sits. The radar itself does not look at your systems.
Components it touches
- Application servers and the hosts they run on. The flaw sits between untrusted input and code or command execution.
- Template engines. The flaw sits between untrusted input and code or command execution.
- Permission checks in APIs and admin surfaces. The flaw sits between one role or tenant and another.
- Multi-tenant services. The flaw sits between one role or tenant and another.
Trust boundaries in play
- Internet-facing entry points. No account is needed. Any instance reachable from outside your perimeter, through a load balancer, gateway, VPN or exposed admin port, is in scope.
- Between untrusted input and code or command execution. An attacker who crosses it can run commands or code with the privileges of the affected service.
- Between one role or tenant and another. An attacker who crosses it can reach data or actions their role should not allow.
Questions to answer about your own systems
- Where does tinyhumansai openhuman run in your systems, and at which version?
- Which of those instances can be reached from the internet or partner networks?
- What can it reach once compromised: which data stores, secrets and services?
Read more
Patches and commits
Sources
- CVE records and CVSS scores from the NVD CVE API. This product uses the NVD API but is not endorsed or certified by the NVD.
- Exploitation status from CISA’s Known Exploited Vulnerabilities catalog.
- Exploit likelihood from FIRST’s Exploit Prediction Scoring System (EPSS), refreshed daily.
- Explanations are written by Veriom from fixed templates over each record’s data, not by a person reviewing each CVE. Descriptions are quoted from the records as published.